Impaired synthesis of adrenal steroid hormones because of steroid 21-hydroxylase deficiency is one of the most common inborn errors of metabolism. To expedite molecular diagnosis in families with 21-hydroxylase deficiency, we have designed a rapid strategy to determine nine of the most common mutations in the 21-hydroxylase gene. According to the mutation to be detected, we apply either of two simple strategies: digestion with adequate restriction enzyme or use of the amplificationcreated restriction site (ACRS) approach and subsequent restriction analysis. Both procedures are rapid and, being nonradioactive, are safer to perform; moreover determination of zygosity in the analyzed mutations requires only one tube per mutation.
INDEXING TERMS: congenital adrenal hyperplasia • heritable disorders • adrenal steroid hormones • amplificationcreated restriction site analysis Congenital adrenal hyperplasia (CAH) is an inherited disorder of cortisol biosynthesis [1] . Although five different enzymes are required to synthesize cortisol in the adrenal cortex-mix, steroid 21-hydroxylase deficiency accounts for Ͼ90% of CAH. The steroid 21-hydroxylase gene, located in the HLA class III gene region on chromosome 6, has a complicated structure with a high degree of variability. An active gene, CYP21, and a highly homologous inactive pseudogene, CYP21P, are located 3Ј from each of the two genes encoding the fourth component of complement C4A and C4B, forming a repeated tandem of the units C4/21OH [2, 3] .
Because 21-hydroxylase deficiency is one of the most common inborn errors of metabolism in humans [4, 5] , procedures are needed that will detect known mutations in the 21-hydroxylase gene to support a rapid diagnosis. We have designed a coordinated strategy to detect nine common 21-hydroxylase mutations, identifying some of them with the amplification-created restriction site (ACRS) method [6] . ACRS, a PCR-based method, can identify previously known allelic mutations in nucleic acid sequences.
Materials and Methods
Subjects. Eight CAH families were selected according to mutations that had been identified previously by means of allele-specific oligonucleotide hybridization.
Preparation of human DNA. Human DNA was prepared from peripheral white blood cells. 10 mL of heparinized blood was mixed with 40 mL of isotonic saline (9 g/L NaCl) and centrifuged at 1500g. The pellet was resuspended in 30 mL of erythrocytes lysis buffer (5 mmol/L MgCl 2 and 20 mmol/L Tris-HCl, pH 7.8) and centrifuged at 3000g. Leukocytes were lysed by adding to 10 mL of lysis buffer (0.2 mol/L NaCl, 1 mmol/L EDTA, and 10 mmol/L Tris-HCl, pH 7.8) containing 10 mg of sodium dodecyl sulfate and 0.4 mg of proteinase K per milliliter (Merck, Darmstadt, Germany). After having shaken this mixture for 2 h at room temperature, we extracted it once with an equal volume of phenol and then twice with chloroform/isoamyl alcohol (24/1 by vol). The DNA was precipitated from the combined extracts by adding 2.5 volumes of isopropanol as described [7] . The two-wavelength absorbance ratio (A 260 /A 280 ) of the DNA preparations was Ͼ1.7. We checked the integrity of the DNA samples by electrophoresis of 2 g of DNA in a 0.9% agarose gel.
Methodology. Primers used were synthesized in our hospital in a DNA synthesizer (Model 392; Applied Biosystems, Foster City, CA); subsequent purification by HPLC was not required. The oligonucleotide probes used for allele-specific oligonucleotide hybridization were essentially those described by Owerbach et al. [5] ; for the 1 
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R356W mutation, we used oligonucleotides described by Speiser et al. [8] . PCR-amplified DNA was blotted onto Hybond-N Nylon membranes and hybridized to specific oligonucleotides with use of Rapid-hyb buffer (both from Johnson & Johnson, Amersham, UK). Deletion/conversion analysis was performed by Southern blot with restriction enzymes BglII and TaqI [8] . Diagnosis of CAH was based on clinical and hormonal criteria [9, 10] . PCR analysis. Nine 21-hydroxylase gene mutations were analyzed by means of the following strategy: Genomic DNA was amplified in two segments by PCR with primers that selectively amplify CYP21. Fragment 1 (Fig. 1 , upper left scheme) represents a 1339-bp segment extending from exon 1 to exon 6. Fragment 2 (Fig. 1 , lower right scheme) is a 2.22-kb fragment extending from the 8-bp deletion in exon 3 to beyond exon 10. These two primary PCR reactions were performed as follows: After a hot start of 2 min at 96°C, we used 35 cycles, each consisting of denaturation for 30 s at 94°C, annealing for 30 s at 60°C, and extension for 2 min (P 1 /P 2 ) or 10 min (P 3 /P 4 ) at 72°C. For the second PCR round we used a 100-fold dilution from each first amplification-with the adequate primers listed in Table 1 and under similar conditions to the primary PCR, except that the extension time was only 1 min. Using fragment 1 as template, we performed a second PCR with the appropriate primers ( Fig. 1 , upper left) to detect P30L, intron 2 (A,C3 G), and exon 3 (8-bp deletion) mutations. Fragment 2 was digested to detect both V281L and R339H mutations at the same time. Fragment 2 was also used as template to perform a second PCR with the appropriate primers ( Fig. 1 , lower right) to detect I172N, Q318X, R356W, and P453S mutations.
The method used to detect point mutations in some of these secondary amplifications involves the gain or loss of at least a single restriction site in the PCR product (R356W, Q318X). Other secondary amplifications were performed with the ACRS method, which enables the detection of any new restriction sites generated by a single-base mutation and of a second mutation generated in vitro by the use of a modified oligonucleotide as a primer (P30L, intron 2, I172N, and P453S).
After the secondary PCR reaction, products were of Fig. 1 . Approximate location of the PCR primers used to detect the following sets of mutations: (upper left scheme) P30L (P 5 /P 6 ), intron 2 (A,C3 G)(P 7 /P 8 ), and exon 3 (8-bp deletion)(P 9 /P 10 ); (lower right scheme) V281 and R339H (P 3 /P 4 ), I172N (P 11 /P 2 ), Q318X (P 12 /P 13 ), R356W (P 14 /P 15 ), and P453S (P 16 /P 17 ). 5Ј ACCTCTCGCACCCCAGTATGACT 3Ј P 5 5Ј GCTCCGGAGCCTCCACCTCG 3Ј P 6 5Ј TTGGAGTTCAGCACCAC 3Ј P 7 5Ј GTGGTGCTGAACTCCAA 3Ј P 8 5Ј ACACCAGCTTGTCTGCAGGAGGCG 3Ј P 9 5Ј AGCCCCCAACTCCTCCTGCA 3Ј P 10 5Ј TGTGGGCTTTCCAGAGC 3Ј P 11 5Ј TCTCTCTCCTCACCTGCAGCATCG 3Ј P 12 5Ј ACCGGCCACTCAGGCTCACTGGG 3Ј P 13 5Ј GCCCAGTTCGTGGTCTAGC 3Ј P 14 5Ј CAGCGACTGCAGGAGGAGCTA 3Ј P 15 5Ј GCTCGGGCTTTCCTCACTCAT 3Ј P 16 5Ј TGTGGTGGAGGCTGGTCCCCG 3Ј P 17 5Ј AGGGCAGGGCGTCCCCGGAGC 3Ј
Modified nucleotides are underlined.
sufficient quality for restriction analysis. PCR products were digested with the appropriate restriction enzyme and subjected to electrophoresis through an agarose gel (1%), agarose/Nu-Sieve gel (0.5%/2.5%) (FMC Bioproducts, Rockland, ME), or polyacrylamide gel (10%), according to the expected length of bands (Table 2 ). All reactions were set up and analyzed in separate areas to prevent contamination from previously amplified material and taking special care during the second PCR reaction. Pipettes with aerosol barrier tips were used, and controls with no genomic DNA template were included in the analyses at all times.
Results and Discussion
We performed this genetic analysis in eight CAH families studied previously by allele-specific oligonucleotide hybridization (Table 3 ). Families pictured in Fig. 2e , g, and h were diagnosed as nonclassical CAH; those in Fig. 2a, d , and f as simple virilizing; and those in Fig. 2b and c as salt-wasting forms.
experimental design for pcr amplification and mutation detection P30L mutation [11] was detected by performing the second PCR with P 5 and P 6 primers. P 5 primer is modified from its original sequence to give rise to an HhaI restriction site when no P30L mutation is present (Fig. 2a) . The P30L mutation also destroys an AcyI restriction site but this restriction enzyme often yielded partial digestions in our hands, leading to wrong results (data not shown). Intron 2 mutation was detected by using a second PCR with P 7 and P 8 primers. The intron 2 site has three possible nucleotide substitutions, two neutral, A or C, and one mutated G, which causes an alternative splice site to be used [12] . P 8 primer is modified to give rise to an HhaI restriction site only when the G nucleotide is present (Fig.  2b) . With this methodology, only one reaction is required, whereas allele-specific PCR, in contrast, requires the use of three different reactions. Exon 3 (8-bp deletion) was detected by means of a second PCR with P 9 and P 10 primers. The amplified product of a nonmutated gene is a 89-bp fragment, whereas exon 3 (8-bp deletion) gives an 81-bp fragment (Fig. 2c) . I172N mutation [13] was detected by means of a second PCR with P 11 and P 2 primers. P 11 primer is modified to generate a TaqI restriction site when this mutation is present (Fig. 2d) .
V281L [14] mutation was detected by means of digestion with Alw 44I restriction enzyme from the P 3 /P 4 -specific CYP21-amplified product (Fig. 2e) , but the R339H mutation [15] was not detected in any of our CAH families. Although we do not include a positive control in our assay, our approach should still detect any R339H mutation present because both V281L and R339H mutations produce a loss of the Alw 44I restriction site. Q318X mutation [16] , which produces a codon stop, was detected by means of a second PCR with P 12 and P 13 primers (neither of them is modified). When the Q318X mutation is present, a PstI restriction site is lost (Fig. 2f) . R356W mutation [17] was detected by means of a second PCR with P 14 and P 15 primers (neither of them is modified) and subsequent digestion with BsofI restriction enzyme (this mutation produces a loss of a BsofI restriction 
See Fig. 2 for explanation of abbreviations.
Clinical Chemistry 43, No. 4, 1997 site) (Fig. 2 g ). P453S mutation [15] was detected also by with a second PCR using P 16 and P 17 primers. P 17 primer was modified to give rise to an HhaI restriction site when P453S mutation is not present (Fig. 2h) .
considerations for the pcr strategy
The number of common mutations and the presence of a highly homologous pseudogene complicate the routine use of molecular techniques for diagnosis of 21-hydroxylase deficiency. Nonetheless, we have developed a simple strategy to determine nine of the most common mutations in the CYP21 gene. Amplification at two independent sites of this gene allows an accurate genotyping of subjects. In contrast to previous methods, e.g., dot-blot analysis (with radioactive probes) or allele-specific PCR (which amplifies normal and mutant alleles in different tubes), this strategy can characterize nine CYP21 gene mutations by using ethidium bromide-stained agarose or polyacrylamide gel electrophoresis and five common restriction enzymes. Moreover, normal and mutant alleles are both amplified in the same reaction tube, thus allowing determination of the zygosity of the mutations. The ligase chain reaction has also been described as an alternative to dot-blot analysis and allele-specific PCR [18] . Although robust, however, the ligase chain reaction is more complex (fluorescently labeled oligonucleotides, asymmetric PCR, and automated sequencing) than our ACRS method. Moreover, the ACRS strategy can be applied to other CYP21 gene mutations in the initial amplified products, leading a more accurate mutational screening of this disease.
In theory, this strategy can also be used to detect CYP21 deletions/conversions. If homozygous deletions/ conversions extend to exons 3, 4, or 5, then P30L, intron 2, and exon 3 (8-bp deletion) mutations would appear in the same allele in a homozygous state and fragment 2 would fail to be amplified. If homozygous deletions/conversions extend to exon 6 or further, neither of the fragments would be amplified. If heterozygous deletions/conversions extend to exons 3, 4, or 5, then P30L, intron 2, and exon 3 (8-bp deletion) mutations would appear in the same allele in a heterozygous state. If, in these last cases, the other allele also carried a P30L, intron 2 or exon 3 (8-bp deletion) mutation, the subject tested would incorrectly be considered a homozygote. Therefore, this methodology does not replace the Southern transfer assay with BglII and TaqI, but it can help to show how far the deletion/conversion extends. Genotyping of parents could also be used to infer the existence of a chromosome so affected.
We have used the described strategy to study three of our families having one deleted allele detected by Southern transfer, but found none of the mutations (data not shown). We suggest that in these three cases, the deletions extend beyond exon 6. Exon 6 (ϫ3 cluster) mutation cannot be detected in this strategy because of P 2 primer matches at this point. "Back-conversions" of CYP21 into CYP21P have been described [18] . In our strategy, a back-mutation around the primer sites for P 2 or P 3 could be amplified, so in these cases we would find several CYP21P mutations in the same allele, suggesting a conversion. Nevertheless, the most common back-conversions are not at either of these two sites.
As a way to take advantage of this strategy, one can use the same PCR amplification products to detect polymorphic sites in the CYP21 gene (Table 4 ) so as to perform a linkage analysis when one or both mutations are not found.
In conclusion, our PCR strategy has a complete concordance with allele-specific oligonucleotide hybridization, requires simple diagnostic tools, avoids the use of radioactivity, and can determine CYP21 mutations rapidly and accurately. In addition, other CYP21 mutations can be enclosed through use of this strategy.
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